Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05774041Terminated

Visualization of the STN and GPi for DBS

Role: lead

NCT04814277Completed

Accuracy Evaluation of SIS Software-based Visualization of New Anatomical Brain Structure

Role: lead

NCT03907319Terminated

SIS Evaluation of the MRI Defined Subthalamic Nucleus*

Role: lead

NCT02902328Completed

Accuracy Evaluation for SIS Software-based Visualization of Anatomical Brain Structures

Role: lead

All 4 trials loaded